PT - JOURNAL ARTICLE AU - Angus SY Fung AU - Dhnanjay Soundappan AU - Daniel E Loewenstein AU - David Playford AU - Geoffrey Strange AU - Rebecca Kozor AU - James Otton AU - Martin Ugander TI - Prognostic association supports indexing size measures in echocardiography by body surface area AID - 10.1101/2021.12.09.21267530 DP - 2022 Jan 01 TA - medRxiv PG - 2021.12.09.21267530 4099 - http://medrxiv.org/content/early/2022/12/21/2021.12.09.21267530.short 4100 - http://medrxiv.org/content/early/2022/12/21/2021.12.09.21267530.full AB - BACKGROUND BSA is the most commonly used metric for body size indexation of echocardiographic measures, but its use in patients who are underweight or obese is questioned (BMI<18.5 kg/m2 or ≥30 kg/m2, respectively).AIMS We aim to use survival analysis to identify an optimal body size indexation metric for echocardiographic measures that would be a better predictor of survival than body surface area (BSA) regardless of body mass index (BMI).METHODS Adult patients with no prior valve replacement were selected from the National Echocardiography Database Australia. Survival analysis was performed for echocardiographic measures both unindexed and indexed to different body size metrics, with 5-year cardiovascular mortality as the primary endpoint.RESULTS Indexation of echocardiographic measures (left ventricular end-diastolic diameter [n=230,109] and mass [n=224,244], left atrial area [n=90,596], aortic sinus diameter [n=90,805], right atrial area [n=59,516], right ventricular diameter [n=3,278], right ventricular outflow tract diameter [n=1,406]) by BSA had better prognostic performance vs unindexed measures (normal weight/overweight: average C-statistic 0.661 vs 0.620; underweight: C-statistic 0.650 vs 0.648; obese: C-statistic 0.627 vs 0.614). Indexation by other body size metrics (lean body mass, height, and/or weight raised to different powers) did not improve prognostic performance versus BSA by a clinically relevant magnitude (average C-statistic increase ≤0.02), with smaller differences in other BMI subgroups.CONCLUSIONS Indexing measures of cardiac and aortic size by BSA improves prognostic performance regardless of BMI, and no other body size metric has a clinically meaningful better performance.Competing Interest StatementD.P. has received modest honorarium from Alerte Echo IQ. The study was funded in part by grants to M.U. from New South Wales Health, Heart Research Australia, and the University of Sydney. The remaining authors declare that they have no competing interests.Funding StatementThis work was supported by by grants (PI Ugander) from New South Wales Health, Heart Research Australia, and the University of Sydney.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the lead ethics committee at the Royal Prince Alfred Hospital (2019/ETH06989). The database used for the study (National Echo Databse Australia) is registered with the Australian New Zealand Clinical Trials Registry (ACTRN12617001387314). Ethical approval has been obtained from the Human Research Ethics Committees at the respective recruiting sites, and the study adheres to the Declaration of Helsinki.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript (unless otherwise specified). Supplementary data in the present study is available upon reasonable request to the authors.